Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000559856 | SCV000644301 | benign | Tuberous sclerosis 2 | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000576099 | SCV000675749 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001558235 | SCV001780139 | likely benign | not provided | 2019-01-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000559856 | SCV002039594 | likely benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000559856 | SCV004236977 | uncertain significance | Tuberous sclerosis 2 | 2023-11-06 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003999261 | SCV004814951 | likely benign | Tuberous sclerosis syndrome | 2023-05-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000559856 | SCV005406217 | likely benign | Tuberous sclerosis 2 | 2024-08-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |